EU CHMP recommends approval of Merck’s Keytruda plus Padcev as perioperative treatment for adults with cisplatin-ineligible resectable muscle-invasive bladder cancer: Rahway, Ne ...
A new experiment is seeking to validate whether living cancer samples can be prepared, operated, monitored, and recovered ...
ASCO is just around the corner, and as usual, there is a fertile crop of high-profile clinical trials to look out for among the late-breaker presentations. To follow – and in no particular order - are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results